Purdue Pharma (Canada) was originally established in Montreal, Quebec in 1956 by physician brothers. Named after the founding physicians, John Purdue Gray and George Frederick Bingham, Purdue Frederick began researching and developing medications for reducing pain.
In 1958, Purdue Pharma (Canada) relocated to Toronto, Ontario and, in 1990, to its current location, a 15-acre site, in Pickering, Ontario.
Today, Purdue Pharma (Canada) continues to be led by physicians and be privately owned. Purdue Pharma (Canada) is part of a privately owned worldwide group of independently associated companies, including Purdue Pharma, Mundipharma and Napp, and employs almost 400 people throughout Canada.
Purdue Pharma (Canada), a privately held pharmaceutical company founded by physicians, has been passionately committed to improving the health and quality of life of Canadians for over 60 years. As a leader in pain management, Purdue Pharma (Canada) has an innovative product portfolio of prescription and non-prescription medications that is focused on supporting the needs of patients and improving patients’ lives in meaningful ways.
Purdue Pharma (Canada) is one of the limited number of pharmaceutical companies in the country that continues to maintain a fully integrated research and development (R&D) formulation laboratory, drug development function and manufacturing capabilities. This means that Purdue Pharma (Canada) participates in the earliest stages of product development and provides a broad variety of business-building opportunities from both national and worldwide sources.
At Purdue Pharma (Canada), we embrace our mission of developing and providing innovative medicines for patients and health care professionals and of supporting quality education for the safe use of our products.